DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Diabetes Mellitus

Intervention: Rosuvastatin (Drug); Rosuvastatin (Drug); Atorvastatin (Drug)

Phase: Phase 2

Status: Active, not recruiting

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
AstraZeneca Crestor Medical Science Director, MD, Study Director, Affiliation: AstraZeneca

Summary

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

Clinical Details

Official title: Randomised, Double-Blind, 52-wk, Parallel-Grp, Multicentre, PIIb Study to Evaluate Effects of Rosuvastatin 10mg, Rosuvastatin 40mg and Atorvastatin 80mg on Urinary Protein Excretion in Hypercholesterolaemic Diabetic Patients With Moderate Proteinuria

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Evaluate effects of rosuvastatin and atorvastatin on urinary protein excretion by evaluation of change in urinary protein/creatinine ratio in patients with Type 1 or 2 diabetes, moderate proteinuria and hypercholesterolemia.

Secondary outcome:

Evaluate change in urinary protein/creatinine ratio, and safety.

Evaluate the change in urinary albumin/creatinine ratio

Evaluate the relationship between renal effects and lipid changes

Evaluate the change in glomerular filtration rate

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- hyperlipidemia

- urinary protein

- diabetes

Exclusion Criteria:

- previous rosuvastatin treatment < 6 months prior to Visit 1

- statin intolerance

- severe hypertension

Locations and Contacts

Research Site, Moron, Argentina

Research Site, Quilmes, Argentina

Research Site, Buenos Aires, Argentina

Reasearch Site, La Plata, Argentina

Research Site, Goiania, Brazil

Research Site, Sao Paulo, Brazil

Research Site, Curitiba, Brazil

Research Site, Fortaleza, Brazil

Research Site, Recife, Brazil

Research Site, Sofia, Bulgaria

Research Site, Varna, Bulgaria

Research Site, Pleven, Bulgaria

Research Site, Plovdiv, Bulgaria

Research Site, Burgas, Bulgaria

Research Site, Veliko Tarnovo, Bulgaria

Research Site, Gabrovo, Bulgaria

Research Site, Gentofte, Denmark

Research Site, Koge, Denmark

Research Site, Hillerod, Denmark

Research Site, Aalborg, Denmark

Research Site, Farso, Denmark

Research Site, Hvidovre, Denmark

Research Site, Blegdamsvej 9, Denmark

Research Site, PESSAC, France

Research Site, Besançon, France

Research Site, ANNONAY, France

Research Site, Bondy, France

Research Site, CORBEIL ESSONNES, France

Research Site, CORSEPT, France

Research Site, CREIL CEDEX, France

Research Site, LA CHAPELLE SUR ERDRE, France

Research Site, Colmar, France

Research Site, NANTES, France

Research Site, QUIMPER, France

Research Site, Grenoble Cedex, France

Research Site, Paris, France

Research Site, Gyor, Hungary

Research Site, Nyiregyhaza, Hungary

Research Site, Debrecen, Hungary

Research site, Budapest, Hungary

Research site, GYULA, Hungary

Research Site, Kecskemét, Hungary

Research Site, Székesfehérvár, Hungary

Research Site, Tatabanya, Hungary

Research Site, Mosonmagyarovar, Hungary

Research Site, BALATONFURED, Hungary

Research Site, HODMEZTVASARHELY, Hungary

Research Site, ZALAEGERSZEG, Hungary

Research Site, Szolnok, Hungary

Research Site, Keszthely, Hungary

Research Site, Baja, Hungary

Research Site, Miskolc, Hungary

Research Site, BERGAMO, Italy

Research Site, CAGLIARI, Italy

Research Site, MILANO, Italy

Research Site, TREVIGLIO, Italy

Research Site, SAN GIOVANNI ROTONDO, Italy

Research Site, Sassari, Italy

Research Site, Durango, Mexico

Research Site, Distrito Federal, Mexico

Research Site, Aguascalientes, Mexico

Research Site, San Luis Potosi, Mexico

Research Site, Zapopan, Mexico

Research Site, Saltillo, Mexico

Research Site, Guadalajara, Mexico

Research Site, Cauntla, Mexico

Research Site, BAIA MARE, Romania

Research Site, TARGU MURES, Romania

Research Site, TIMISOARA, Romania

Research Site, CRAIOVA, Romania

Research Site, Bucharest, Romania

Research Site, Brasov, Romania

Research Site, Lasi, Romania

Research Site, Phoenix, Arizona, United States

Research Site, Avondale, Arizona, United States

Research Site, Jonesboro, Arkansas, United States

Research Site, VANCOUVER, British Columbia, Canada

Research Site, Acireale, CT, Italy

Research Site, Riverside, California, United States

Research Site, West Hills, California, United States

Research Site, Santa Ana, California, United States

Research Site, PASADENA, California, United States

Research Site, Firenze, FI, Italy

Research Site, Hollywood, Florida, United States

Research Site, West Palm Beach, Florida, United States

Research Site, JACKSONVILLE, Florida, United States

Research Site, Augusta, Georgia, United States

Research Site, Topeka, Kansas, United States

Research Site, Springfield, Massachusetts, United States

Research Site, Detroit, Michigan, United States

Research Site, St. Louis, Missouri, United States

Research Site, Columbia, Missouri, United States

Research Site, Orchard Park, New York, United States

Research Site, Stony Brook, New York, United States

Research Site, Winston Salem, North Carolina, United States

Research Site, Kettering, Ohio, United States

Research Site, Cincinnati, Ohio, United States

Research Site, OSHAWA, Ontario, Canada

Research Site, OTTAWA, Ontario, Canada

Research Site, RICHMOND HILL, Ontario, Canada

Research Site, SCARBOROUGH, Ontario, Canada

Research Site, THUNDER BAY, Ontario, Canada

Research Site, Courtice, Ontario, Canada

Research Site, North York, Ontario, Canada

Research Site, Pittsburg, Pennsylvania, United States

Research Site, MONTREAL, Quebec, Canada

Research Site, Greenfield Park, Quebec, Canada

Research Site, Roma, RM, Italy

Research Site, Columbia, South Carolina, United States

Research Site, San Antonio, Texas, United States

Research Site, Lubbock, Texas, United States

Research Site, Dallas, Texas, United States

Research Site, Houston, Texas, United States

Research Site, Ogden, Utah, United States

Research Site, Sottomarnia Di Chioggia, VE, Italy

Research Site, Milwaukee, Wisconsin, United States

Additional Information

AstraZeneca Clinical Trial Information - Outside US

Starting date: January 2006
Ending date: April 2009
Last updated: May 1, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012